Cann Group Ltd has released a press release.
Results of Share Purchase Plan offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cann
- Appendix 4E & Audited Financial Statements for FY21
- Cann proceeds with Schedule 3 CBD registration program
- Investor presentation regarding capital raising
- Update on recovery of missing funds
- Cann provides further revenue update
Later from Cann
- Cann granted GMP licence & other regulatory updates
- Cann to begin recruitment for CBD phase 3 clinical trial
- Mildura facility practical completion & ODC permit granted
- Satipharm CBD products get green light from UK FSA
- Evaluation and option agreement with GSK Consumer Healthcare
Follow Cann into a list and get an email when it puts out news.
Follow Cann